APA

Broom R. J., Hinder V., Sharples K., Proctor J., Duffey S., Pollard S., Fong P. C. C., Forgeson G., Harris D. L., Jameson M. B., O'Donnell A., North R. T., Deva S., Hanning F. J., Grey A. & Findlay M. P. N. (20150916). Everolimus and zoledronic acid in patients with renal cell carcinoma with bone metastases: a randomized first-line phase II trial. : Clinical genitourinary cancer.

Chicago

Broom Reuben J, Hinder Victoria, Sharples Katrina, Proctor Janie, Duffey Steven, Pollard Stephanie, Fong Peter C C, Forgeson Garry, Harris Dean L, Jameson Michael B, O'Donnell Anne, North Richard T, Deva Sanjeev, Hanning Fritha J, Grey Andrew and Findlay Michael P N. 20150916. Everolimus and zoledronic acid in patients with renal cell carcinoma with bone metastases: a randomized first-line phase II trial. : Clinical genitourinary cancer.

Harvard

Broom R. J., Hinder V., Sharples K., Proctor J., Duffey S., Pollard S., Fong P. C. C., Forgeson G., Harris D. L., Jameson M. B., O'Donnell A., North R. T., Deva S., Hanning F. J., Grey A. and Findlay M. P. N. (20150916). Everolimus and zoledronic acid in patients with renal cell carcinoma with bone metastases: a randomized first-line phase II trial. : Clinical genitourinary cancer.

MLA

Broom Reuben J, Hinder Victoria, Sharples Katrina, Proctor Janie, Duffey Steven, Pollard Stephanie, Fong Peter C C, Forgeson Garry, Harris Dean L, Jameson Michael B, O'Donnell Anne, North Richard T, Deva Sanjeev, Hanning Fritha J, Grey Andrew and Findlay Michael P N. Everolimus and zoledronic acid in patients with renal cell carcinoma with bone metastases: a randomized first-line phase II trial. : Clinical genitourinary cancer. 20150916.